Drug intelligence / Profile preview

niuhuang yijin tablet

Development stage: Unknown
Lead developer: Shandong Wohua Pharmaceutical
Modality: Small Molecules
Administration: Oral

Overview

Niuhuang Yijin Tablet (牛黄益金片) is a traditional Chinese medicine (TCM) formulation developed and marketed by Shandong Wohua Pharmaceutical. It is an oral tablet indicated for the treatment of respiratory disorders, specifically targeting symptoms such as dry throat and sore throat. As a complex herbal preparation, its formulation includes Niuhuang (Calculus Bovis/bezoar) among other herbal components. The product is part of Shandong Wohua's portfolio of approved traditional patent medicines in China.

Brand names: Niuhuang Yijin Tablet牛黄益金片
Other names: Niuhuang Yijin Pian

Beyond the preview

Go deeper on niuhuang yijin tablet.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on niuhuang yijin tablet.

Explore the full profile